Literature DB >> 16267686

Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.

Gerald Schwerdt1, Nader Gordjani, Andreas Benesic, Ruth Freudinger, Brigitte Wollny, Antje Kirchhoff, Michael Gekle.   

Abstract

Ifosfamide (ifo) is a commonly used drug in chemotherapy. It is metabolized to acrolein (acro) and chloroacetaldehyde (CAA), which are thought to be responsible for renal side effects. We studied the effects of ifo and cyclophosphamide (cyclo) as well as their metabolites, acro and CAA, on cellular protein content, necrosis, apoptosis and cytosolic calcium concentration using a human proximal tubule cell line. The protein content decreased during acro or CAA administration (15 to 300 micromol/l), but not during ifo or cyclo exposure over a time period of up to 72 h. Mild apoptosis was induced only by high acro (150, 300 micromol/l) and low CAA concentrations (15, 75 micromol/l) and only in a narrow time window (24 h). Necrosis was increased after exposure to acro or CAA at all concentrations. CAA was more potent than acro. Ifo and cyclo did not induce necrosis or apoptosis. Glutathione abolished CAA-induced cell death. Cytosolic calcium concentrations increased after acro or CAA administration and showed an oscillating pattern. Cytosolic Ca(2+) chelation did not prevent necrosis. We conclude that neither ifo nor cyclo induce cell damage, but that their metabolites acro and CAA induce cell death. This cell death occurs mainly by necrosis and not by apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267686     DOI: 10.1007/s00467-005-2006-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  47 in total

1.  Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites.

Authors:  W Seefelder; H-U Humpf; G Schwerdt; R Freudinger; M Gekle
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-15       Impact factor: 4.219

Review 2.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.

Authors:  A Suarez; H McDowell; P Niaudet; E Comoy; F Flamant
Journal:  J Clin Oncol       Date:  1991-12       Impact factor: 44.544

4.  Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.

Authors:  J E Springate
Journal:  J Appl Toxicol       Date:  1997 Jan-Feb       Impact factor: 3.446

5.  Dechloroethylation of ifosfamide and neurotoxicity.

Authors:  M P Goren; R K Wright; C B Pratt; F E Pell
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

6.  Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.

Authors:  C Woodland; S Ito; C P Granvil; I W Wainer; J Klein; G Koren
Journal:  Life Sci       Date:  2000-11-24       Impact factor: 5.037

7.  Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.

Authors:  J Springate; K Chan; H Lu; S Davies; M Taub
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-06       Impact factor: 2.416

8.  Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture.

Authors:  M Mohrmann; S Ansorge; U Schmich; B Schönfeld; M Brandis
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  Effects of calcium flux inhibitors on contracture and calcium content during inhibition of high energy phosphate production in cultured heart cells.

Authors:  Y Hasin; A Doorey; W H Barry
Journal:  J Mol Cell Cardiol       Date:  1984-09       Impact factor: 5.000

Review 10.  Endoplasmic reticulum, Bcl-2 and Ca2+ handling in apoptosis.

Authors:  D Ferrari; P Pinton; G Szabadkai; M Chami; M Campanella; T Pozzan; R Rizzuto
Journal:  Cell Calcium       Date:  2002 Nov-Dec       Impact factor: 6.817

View more
  10 in total

1.  Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.

Authors:  Gerald Schwerdt; Antje Kirchhoff; Ruth Freudinger; Brigitte Wollny; Andreas Benesic; Michael Gekle
Journal:  Pediatr Nephrol       Date:  2007-02-02       Impact factor: 3.714

2.  Ifosfamide toxicity in cultured proximal renal tubule cells.

Authors:  James Springate; Mary Taub
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

3.  Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease.

Authors:  Abiodun Omoloja; Judith Jerry-Fluker; Derek K Ng; Alison G Abraham; Susan Furth; Bradley A Warady; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2013-04-13       Impact factor: 3.714

4.  Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.

Authors:  Ryan J Hansen; Susan M Ludeman; Sari J Paikoff; Anthony E Pegg; M Eileen Dolan
Journal:  DNA Repair (Amst)       Date:  2007-05-07

5.  Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells.

Authors:  Adam Szadkowski; Charles R Myers
Journal:  Toxicology       Date:  2007-10-10       Impact factor: 4.221

6.  Nitrosative stress, protein tyrosine nitration, PARP activation and NAD depletion in the kidneys of rats after single dose of cyclophosphamide.

Authors:  Premila Abraham; Suganthy Rabi
Journal:  Clin Exp Nephrol       Date:  2009-03-07       Impact factor: 2.801

Review 7.  Tobacco and the pediatric chronic kidney disease population.

Authors:  Abiodun Omoloja; Vida L Tyc
Journal:  Pediatr Nephrol       Date:  2014-06-03       Impact factor: 3.714

8.  Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney.

Authors:  Hyoung-Yun Han; Mi-Sun Choi; Seokjoo Yoon; Je-Won Ko; Sang-Kyum Kim; Tae-Won Kim
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

9.  Effect of glutathione depletion on Ifosfamide nephrotoxicity in rats.

Authors:  Sudha Garimella-Krovi; James E Springate
Journal:  Int J Biomed Sci       Date:  2008-09

10.  The Impact of the Nephrotoxin Ochratoxin A on Human Renal Cells Studied by a Novel Co-Culture Model Is Influenced by the Presence of Fibroblasts.

Authors:  Gerald Schwerdt; Michael Kopf; Michael Gekle
Journal:  Toxins (Basel)       Date:  2021-03-18       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.